Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism

被引:90
作者
Hu, X. [1 ]
Bonde, Y. [2 ,3 ]
Eggertsen, G. [1 ]
Rudling, M. [2 ,3 ]
机构
[1] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Lab Med, Div Clin Chem, S-14186 Huddinge, Sweden
[2] Karolinska Inst, Karolinska Univ Hosp Huddinge, Ctr Endocrinol Metab & Diabet, Metab Unit,Dept Med, S-14186 Huddinge, Sweden
[3] Karolinska Inst, Karolinska Univ Hosp Huddinge, Dept Biosci & Nutr, Mol Nutr Unit, S-14186 Huddinge, Sweden
基金
瑞典研究理事会;
关键词
GROWTH-FACTOR; 15; CHOLESTEROL; 7-ALPHA-HYDROXYLASE; THYROID-HORMONE; TRANSPORTER; METABOLISM; FXR; IDENTIFICATION; SUPPRESSION; HOMEOSTASIS; INFUSION;
D O I
10.1111/joim.12140
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Objective: Bile acid (BA) synthesis is regulated by negative feedback end-product inhibition, initiated by farnesoid X receptors (FXRs) in liver and gut. Studies on cholic acid (CA)-free Cyp8b1-/- mice have concluded that CA is a potent suppressor of BA synthesis. Cyp8b1-/- mice have increased BA synthesis and an enlarged BA pool, a phenotype shared with bile-duct-ligated, antibiotics-administered and with germ-free mice. Studies on such mice have concluded BA synthesis is induced due to reduced hormonal signalling by fibroblast growth factor (FGF)15 from intestine to liver. A mutual finding in these models is that potent FXR-agonistic BAs are reduced. We hypothesized that the absence of the potent FXR agonist deoxycholic acid (DCA) may be important for the induction of BA synthesis in these situations. Design: Two of these models were investigated, antibiotic treatment and Cyp8b1-/- mice and their combination. Secondary BA formation was inhibited by ampicillin (AMP) given to wild-type and Cyp8b1-/- mice. We then administered CA, chenodeoxycholic acid (CDCA) or DCA to AMP-treated Cyp8b1-/- mice. Results: Our data show that the phenotype of AMP-treated wild-type mice resembles that of Cyp8b1-/- mice with fourfold induced Cyp7a1 expression, increased intestinal apical sodium-dependent BA transporter expression and increased hepatic BA levels. We also show that reductions in the FXR-agonistic BAs CDCA, CA, DCA or lithocholic acid cannot explain this phenotype; instead, it is likely due to increases in levels of α- and β-muricholic BAs and ursodeoxycholic acid, three FXR-antagonistic BAs. Conclusions: Our findings reveal a potent positive feedback mechanism for regulation of BA synthesis in mice that appears to be sufficient without endocrine effects of FGF15 on Cyp7a1. This mechanism will be fundamental in understanding BA metabolism in both mice and humans. © 2013 The Association for the Publication of the Journal of Internal Medicine.
引用
收藏
页码:27 / 38
页数:12
相关论文
共 36 条
[1]
Stimulation of murine biliary cholesterol secretion by thyroid hormone is dependent on a functional ABCG5/G8 complex [J].
Bonde, Ylva ;
Plosch, Torsten ;
Kuipers, Folkert ;
Angelin, Bo ;
Rudling, Mats .
HEPATOLOGY, 2012, 56 (05) :1828-1837
[2]
THE METABOLISM OF CHENODEOXYCHOLIC ACID TO BETA-MURICHOLIC ACID IN RAT-LIVER [J].
BOTHAM, KM ;
BOYD, GS .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1983, 134 (01) :191-196
[3]
Regulation of ileal bile acid-binding protein expression in Caco-2 cells by ursodeoxycholic acid: Role of the farnesoid X receptor [J].
Campana, G ;
Pasini, P ;
Roda, A ;
Spampinato, S .
BIOCHEMICAL PHARMACOLOGY, 2005, 69 (12) :1755-1763
[4]
Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice [J].
Dawson, PA ;
Haywood, J ;
Craddock, AL ;
Wilson, M ;
Tietjen, M ;
Kluckman, K ;
Maeda, N ;
Parks, JS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (36) :33920-33927
[5]
Feedback regulation of bile acid synthesis in primary human hepatocytes:: Evidence that CDCA is the strongest inhibitor [J].
Ellis, E ;
Axelson, M ;
Abrahamsson, A ;
Eggertsen, G ;
Thörne, A ;
Nowak, G ;
Ericzon, BG ;
Björkhem, I ;
Einarsson, C .
HEPATOLOGY, 2003, 38 (04) :930-938
[6]
Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19 [J].
Galman, C. ;
Angelin, B. ;
Rudling, M. .
JOURNAL OF INTERNAL MEDICINE, 2011, 270 (06) :580-588
[7]
Monitoring hepatic cholesterol 7α-hydroxylase activity by assay of the stable bile acid intermediate 7α-hydroxy-4-cholesten-3-one in peripheral blood [J].
Gälman, C ;
Arvidsson, I ;
Angelin, B ;
Rudling, M .
JOURNAL OF LIPID RESEARCH, 2003, 44 (04) :859-865
[8]
Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method [J].
Garcia-Canaveras, Juan C. ;
Teresa Donato, M. ;
Castell, Jose V. ;
Lahoz, Agustin .
JOURNAL OF LIPID RESEARCH, 2012, 53 (10) :2231-2241
[9]
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis [J].
Goodwin, B ;
Jones, SA ;
Price, RR ;
Watson, MA ;
McKee, DD ;
Moore, LB ;
Galardi, C ;
Wilson, JG ;
Lewis, MC ;
Roth, ME ;
Maloney, PR ;
Willson, TM ;
Kliewer, SA .
MOLECULAR CELL, 2000, 6 (03) :517-526
[10]
Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis [J].
Holt, JA ;
Luo, GZ ;
Billin, AN ;
Bisi, J ;
McNeill, YY ;
Kozarsky, KF ;
Donahee, M ;
Wang, DY ;
Mansfield, TA ;
Kliewer, SA ;
Goodwin, B ;
Jones, SA .
GENES & DEVELOPMENT, 2003, 17 (13) :1581-1591